• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜酸性粒细胞增多、肌痛和皮肤挛缩的罕见病例:再探舒尔曼病

An unusual case of eosinophilia, myalgia and skin contractures: Shulman's disease revisited.

作者信息

Anadure R K, Shankar S, Mohimen Aneesh, Pemmaraju Arpitha, Kalita Jitumani

机构信息

Senior Advisor (Neurology), Command Hospital (Air Force), Bengaluru, India.

Professor & Head, Department of Internal Medicine, Armed Forces Medical College, Pune 411040, India.

出版信息

Med J Armed Forces India. 2022 Sep;78(Suppl 1):S273-S276. doi: 10.1016/j.mjafi.2019.12.006. Epub 2020 Mar 12.

DOI:10.1016/j.mjafi.2019.12.006
PMID:36147388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9485746/
Abstract

Shulman's disease (eosinophilic fasciitis) is a very rare autoimmune disorder with an unknown etiopathogenesis. During the initial period of disease, it usually causes limb and trunk edema followed by collagenous thickening of the subcutaneous fascia. Eosinophilia is a predominant laboratory finding during the initial phase of the disease and less prominent in the later phases. Patients may also present with arthritis, myositis, peripheral neuropathy, and rarely pleuropericarditis. Here, we are reporting a case of eosinophilic fasciitis presenting with vague constitutional symptoms, fever, and peripheral blood eosinophilia followed by rapidly evolving skin tightening with joint contractures and muscle stiffness, which misled the treating team toward Scleroderma and its overlap syndromes. The diagnosis was finally clinched by a full-thickness skin biopsy along with underlying fascia and muscle tissue from an effected area, with a gratifying treatment response to standard immune suppression.

摘要

舒尔曼病(嗜酸性筋膜炎)是一种非常罕见的自身免疫性疾病,其发病机制不明。在疾病初期,它通常会导致肢体和躯干水肿,随后皮下筋膜出现胶原性增厚。嗜酸性粒细胞增多是疾病初期的主要实验室检查发现,在后期则不太明显。患者还可能出现关节炎、肌炎、周围神经病变,很少出现胸膜心包炎。在此,我们报告一例嗜酸性筋膜炎病例,该病例最初表现为模糊的全身症状、发热和外周血嗜酸性粒细胞增多,随后迅速出现皮肤紧绷伴关节挛缩和肌肉僵硬,这使治疗团队误诊为硬皮病及其重叠综合征。最终通过对受累部位进行全层皮肤活检以及取其下方的筋膜和肌肉组织确诊,对标准免疫抑制治疗反应良好。

相似文献

1
An unusual case of eosinophilia, myalgia and skin contractures: Shulman's disease revisited.嗜酸性粒细胞增多、肌痛和皮肤挛缩的罕见病例:再探舒尔曼病
Med J Armed Forces India. 2022 Sep;78(Suppl 1):S273-S276. doi: 10.1016/j.mjafi.2019.12.006. Epub 2020 Mar 12.
2
A histopathologic comparison of Shulman's syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome.舒尔曼综合征(嗜酸性粒细胞增多性弥漫性筋膜炎)与嗜酸性粒细胞增多性肌痛综合征相关筋膜炎的组织病理学比较。
J Am Acad Dermatol. 1992 Jan;26(1):95-100. doi: 10.1016/0190-9622(92)70014-7.
3
[Eosinophilia heralding the diagnosis of eosinophilic fasciitis (Shulman's disease)].嗜酸性粒细胞增多预示嗜酸性筋膜炎(舒尔曼病)的诊断
Rev Med Interne. 2017 Dec;38(12):840-843. doi: 10.1016/j.revmed.2017.07.010. Epub 2017 Sep 1.
4
Generalized morphea with peripheral eosinophilia, fasciitis and myositis.伴有外周嗜酸性粒细胞增多、筋膜炎和肌炎的泛发性硬斑病。
Int J Dermatol. 1980 Apr;19(3):149-53. doi: 10.1111/j.1365-4362.1980.tb00283.x.
5
[Eosinophilic fasciitis (Shulman's disease): Diagnostic and therapeutic review].[嗜酸性筋膜炎(舒尔曼病):诊断与治疗综述]
Rev Med Interne. 2015 Nov;36(11):738-45. doi: 10.1016/j.revmed.2015.08.002. Epub 2015 Sep 16.
6
Eosinophilic Fasciitis - Clinical Features and Therapeutic Management.嗜酸性筋膜炎 - 临床特征与治疗管理。
Acta Dermatovenerol Croat. 2020 Dec;28(3):190-192.
7
[Shulman's syndrome (eosinophilic fasciitis)].[舒尔曼综合征(嗜酸性筋膜炎)]
Hautarzt. 2009 Apr;60(4):278-81. doi: 10.1007/s00105-009-1741-1.
8
[Eosinophilic fasciitis (Shulman's disease): a case series of 11 patients].[嗜酸性筋膜炎(舒尔曼病):11例患者的病例系列]
Rev Med Interne. 2010 Aug;31(8):535-9. doi: 10.1016/j.revmed.2010.03.344. Epub 2010 May 20.
9
[Eosinophilic fasciitis and related diseases].[嗜酸性筋膜炎及相关疾病]
An Med Interna. 1999 Sep;16(9):477-83.
10
[Eosinophilic fasciitis (Shulman syndrome)].[嗜酸性筋膜炎(舒尔曼综合征)]
Schweiz Med Wochenschr. 2000 Feb 5;130(5):156-60.

本文引用的文献

1
Eosinophilic Skin Diseases: A Comprehensive Review.嗜酸性皮肤病:全面综述
Clin Rev Allergy Immunol. 2016 Apr;50(2):189-213. doi: 10.1007/s12016-015-8485-8.
2
Diagnosis and classification of eosinophilic fasciitis.嗜酸性筋膜炎的诊断和分类。
Autoimmun Rev. 2014 Apr-May;13(4-5):379-82. doi: 10.1016/j.autrev.2014.01.019. Epub 2014 Jan 11.
3
Eosinophilic fasciitis (Shulman disease).嗜酸性筋膜炎(舒尔曼病)。
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):449-58. doi: 10.1016/j.berh.2012.08.001.
4
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.嗜酸性筋膜炎(舒尔曼病):34 例患者系列研究中对治疗管理的新见解。
Rheumatology (Oxford). 2012 Mar;51(3):557-61. doi: 10.1093/rheumatology/ker366. Epub 2011 Nov 25.
5
Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature.嗜酸性筋膜炎:人口统计学、疾病模式及治疗反应:12例报告并文献复习
Int J Dermatol. 2008 Jan;47(1):29-35. doi: 10.1111/j.1365-4632.2007.03544.x.
6
Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.嗜酸性筋膜炎:两例报告及对涉及预测预后临床变量的文献的系统综述
Clin Rheumatol. 2007 Sep;26(9):1445-51. doi: 10.1007/s10067-006-0525-6. Epub 2007 Mar 8.
7
Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis.嗜酸性筋膜炎患者血清金属蛋白酶组织抑制剂-1和-2水平
Br J Dermatol. 2004 Aug;151(2):407-12. doi: 10.1111/j.1365-2133.2004.06062.x.
8
Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.系统性硬化症、局限性硬皮病和嗜酸性筋膜炎中血液嗜酸性粒细胞增多的频率、水平及意义。
J Am Acad Dermatol. 1987 Oct;17(4):648-56. doi: 10.1016/s0190-9622(87)70251-5.
9
Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases.嗜酸性筋膜炎:52例患者的临床谱及治疗反应
Semin Arthritis Rheum. 1988 May;17(4):221-31. doi: 10.1016/0049-0172(88)90008-x.
10
Diffuse fasciitis with eosinophilia: a new syndrome?
Trans Assoc Am Physicians. 1975;88:70-86.